BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26185316)

  • 21. Disruption of ETV6 in intron 2 results in upregulatory and insertional events in childhood acute lymphoblastic leukaemia.
    Jalali GR; An Q; Konn ZJ; Worley H; Wright SL; Harrison CJ; Strefford JC; Martineau M
    Leukemia; 2008 Jan; 22(1):114-23. PubMed ID: 17972957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ETV6/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia.
    Zen PR; Capra ME; Silla LM; Loss JF; Fernandes MS; Jacques SM; Paskulin GA
    Cancer Genet Cytogenet; 2009 Jan; 188(2):112-7. PubMed ID: 19100516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
    Alm SJ; Engvall C; Asp J; Palmqvist L; Abrahamsson J; Fogelstrand L
    Int J Lab Hematol; 2017 Apr; 39(2):121-128. PubMed ID: 28004528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of ETV6 and RUNX1 gene rearrangements using fluorescence in situ hybridization in Mexican patients with acute lymphoblastic leukemia: experience at a single institution.
    Pérez-Vera P; Montero-Ruiz O; Frías S; Ulloa-Avilés V; Cárdenas-Cardós R; Paredes-Aguilera R; Rivera-Luna R; Carnevale A
    Cancer Genet Cytogenet; 2005 Oct; 162(2):140-5. PubMed ID: 16213362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia.
    Kim J; Lyu CJ; Shin S; Lee ST; Choi JR
    Ann Lab Med; 2016 Sep; 36(5):475-80. PubMed ID: 27374714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Calasanz MJ; Garate L; San Jose-Eneriz E; Cordeu L; Prosper F; Heiniger A; Torres A
    Clin Cancer Res; 2006 Aug; 12(16):4845-50. PubMed ID: 16914570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
    Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing.
    Jin Y; Wang X; Hu S; Tang J; Li B; Chai Y
    Cancer Med; 2016 Feb; 5(2):337-51. PubMed ID: 26711002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice.
    van der Weyden L; Giotopoulos G; Rust AG; Matheson LS; van Delft FW; Kong J; Corcoran AE; Greaves MF; Mullighan CG; Huntly BJ; Adams DJ
    Blood; 2011 Jul; 118(4):1041-51. PubMed ID: 21628403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of ETV6/RUNX1 Fusion and Additional Abnormalities Involving ETV6 and/or RUNX1 Genes Using FISH Technique in Patients with Childhood Acute Lymphoblastic Leukemia.
    Aydin C; Cetin Z; Manguoglu AE; Tayfun F; Clark OA; Kupesiz A; Akkaya B; Karauzum SB
    Indian J Hematol Blood Transfus; 2016 Jun; 32(2):154-61. PubMed ID: 27065576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of patients with TEL-AML1-positive acute lymphoblastic leukemia with single or multiple fusions.
    Al-Sweedan SA; Neglia JP; Steiner ME; Bostrom BC; Casey T; Hirsch BA
    Pediatr Blood Cancer; 2007 May; 48(5):510-4. PubMed ID: 16763978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.
    Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y
    Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presenting features of 201 children with acute lymphoblastic leukemia: comparison according to presence or absence of ETV6/RUNX1 rearrangement.
    Alvarez Y; Caballín MR; Gaitán S; Pérez A; Bastida P; Ortega JJ; Cervera J; Verdeguer A; Tasso M; Aventín A; Badell I; Guitart M; Melo M; Granada I; Javier G; Dastugue N; Robert A; Coll MD
    Cancer Genet Cytogenet; 2007 Sep; 177(2):161-3. PubMed ID: 17854676
    [No Abstract]   [Full Text] [Related]  

  • 34. Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Bokemeyer A; Eckert C; Meyr F; Koerner G; von Stackelberg A; Ullmann R; Türkmen S; Henze G; Seeger K
    Haematologica; 2014 Apr; 99(4):706-14. PubMed ID: 24241490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DM expression is elevated in ETV6-AML1 translocation-positive pediatric acute lymphoblastic leukemia.
    Jastaniah WA; Alessandri AJ; Reid GS; Schultz KR
    Leuk Res; 2006 Apr; 30(4):487-9. PubMed ID: 16191436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
    Wang Y; Zeng HM; Zhang LP
    Ital J Pediatr; 2018 Aug; 44(1):94. PubMed ID: 30115129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotype.
    Alessandri AJ; Reid GS; Bader SA; Massing BG; Sorensen PH; Schultz KR
    Br J Haematol; 2002 Feb; 116(2):266-72. PubMed ID: 11841426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
    Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low Frequency of ETV6-RUNX1 (t 12; 21) in Saudi Arabian Pediatric Acute Lymphoblastic Leukemia Patients: Association with Clinical Parameters and Early Remission.
    Aljamaan K; Aljumah TK; Aloraibi S; Absar M; Iqbal Z
    Asian Pac J Cancer Prev; 2015; 16(17):7523-7. PubMed ID: 26625756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.